Abstract
Protein oxidation has been demonstrated in preeclampsia, but this finding has not been established in other hypertensive disorders in pregnancy (HDP). The present study comparatively evaluated ischemia modified albumin (IMA) and advanced oxidation protein products (AOPP) in different HDP and investigated their association with total antioxidant activity (AOA) and total thiols. There was a significant increase in AOPP and IMA, a significant decrease in AOA, total thiols and albumin in every HDP compared to controls. Among HDP groups, eclampsia patients showed more significant change in each of the parameter. IMA and AOPP were negatively associated with AOA in every HDP and with total thiols only in eclampsia. The present study supports the hypothesis of oxidative stress, as evidenced by increased protein oxidation, decreased antioxidant status and significant negative association between protein oxidation and AOA in every HDP. The imbalance of prooxidants and antioxidants was further augmented in eclampsia.
Similar content being viewed by others
Abbreviations
- AOPP:
-
Advanced oxidation protein products
- IMA:
-
Ischemia modified albumin
- AOA:
-
Total antioxidant activity
- ROS:
-
Reactive oxygen species
- HDP:
-
Hypertensive disorders in pregnancy
References
Mbachu II, Udigwe GO, Okafor CI, Umeonunihu OS, Ezeama C, Eleje GU. The pattern and obstetric outcome of hypertensive disorders of pregnancy in Nnewi, Nigeria. Niger J Med. 2013;22(2):117–22.
Watanabe K, Mori T, Iwasaki A, Kimura C, Matsushita H, Shinohara K, et al. Increased oxygen free radical production during pregnancy may impair vascular reactivity in preeclamptic women. Hypertens Res. 2013;36(4):356–60.
Rani N, Dhingra R, Arya DS, Kalaivani M, Bhatla N, Kumar R. Role of oxidative stress markers and antioxidants in the placenta of preeclamptic patients. J Obstet Gynaecol Res. 2010;36(6):1189–94.
Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal. 2001;3(2):293–311.
Grzebyk E, Piwowar A. Glycoxidative modification of albumin in medical research. Pol Merkur Lekarski. 2013;34(202):239–42.
Griffiths HR, Møller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, et al. Biomarkers. Mol Asp Med. 2002;23(1–3):101–208.
Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329(1–2):23–38.
Piwowar A. Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property. Pol Merkur Lekarski. 2010;28(164):166–9.
Karacay O, Sepici-Dincel A, Karcaaltincaba D, Sahin D, Yalvaç S, Akyol M, et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24–36 weeks of gestation. Diabetes Res Clin Pract. 2010;89(3):231–8.
Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischemia modified albumin. Heart. 2006;92(1):113–4.
Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis. 2007;23(2–3):216–20.
Ma SG, Wei CL, Hong B, Yu WN. Ischemia dified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics (Sao Paulo). 2011;66(10):1677–80.
D’souza JM, Pai VR, Harish S, Shriyan C, D’souza N. IMA and IMAR in serum and saliva of preeclampsia: a preliminary study. Hypertens Pregnancy. 2014;33(4):440–8.
Huang QT, Zhong M, Tian JW, Hou FF. Higher plasma AOPP is associated with increased proteinuria excretion and decreased glomerular filtration rate in pre-eclamptic women. Pregnancy Hypertens. 2013;3(1):16–20.
Van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy. 2008;27(2):159–67.
Gafsou B, Lefèvre G, Hennache B, Houfflin Debarge V, Ducloy-Bouthors AS. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? Hypertens Pregnancy. 2010;29(1):101–11.
Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158(4):892–8.
Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med. 2000;19(4):311–5.
Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304–13.
Ellman GL. Measurement of total thiols in plasma. Arch Biochem Biophys. 1959;82:70.
Webster D. A study of the interaction of bromocresol green with isolated serum globulin fractions. Clin Chim Acta. 1974;53(1):109–15.
Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001;54(5):356–61.
Miranda Guisado ML, Vallejo-Vaz AJ, García Junco PS, Jiménez Jiménez L, García Morillo S, Muñiz Grijalvo O, et al. Abnormal levels of antioxidant defenses in a large sample of patients with hypertensive disorders of pregnancy. Hypertens Res. 2012;35(3):274–8.
Mori T, Watanabe K, Iwasaki A, Kimura C, Matsushita H, Shinohara K, et al. Differences in vascular reactivity between pregnant women with chronic hypertension and preeclampsia. Hypertens Res. 2014;37(2):145–50.
Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev. 2000; 32(3–4):307–26.
Noyan T, Güler A, Sekeroğlu MR, Kamaci M. Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia. Aust NZ J Obstet Gynaecol. 2006;46(6):486–91.
Huang QT, Wang SS, Zhang M, Huang LP, Tian JW, Yu YH, et al. Advanced oxidation protein products enhances soluble Fmslike tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia. Placenta. 2013;34(10):949–52.
Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med. 2013;65:244–53.
Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41(6):1211–9.
Raijmakers MT, Zusterzeel PL, Steegers EA, Hectors MP, Demacker PN, Peters WH. Plasma thiol status in preeclampsia. Obstet Gynecol. 2000;95(2):180–4.
Raijmakers MT, Zusterzeel PL, Roes EM, Steegers EA, Mulder TP, Peters WH. Oxidized and free whole blood thiols in preeclampsia. Obstet Gynecol. 2001;97(2):272–6.
Adiga U, D’souza V, Kamath A, Mangalore N. Antioxidant activity and lipid peroxidation in preeclampsia. J Chin Med Assoc. 2007;70(10):435–8.
Nasrollahi S, Hoseini Panah SM, Tavilani H, Tavasoli S, Naderan M, Shoar S. Antioxidant status and serum levels of selectins in pre-eclampsia. J Obstet Gynaecol. 2015;35(1):16–8.
Acknowledgments
The authors acknowledge the cooperation given by Ms. Mamatha, Chief librarian, Yenepoya University and Ms. Shobha, Laboratory technician, Chirashree Maternity Hospital, Surathkal, Mangalore.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest regarding the publication of the paper.
Rights and permissions
About this article
Cite this article
D’souza, J.M.P., Harish, S., Pai, V.R. et al. Increased Oxidatively Modified Forms of Albumin in Association with Decreased Total Antioxidant Activity in Different Types of Hypertensive Disorders of Pregnancy. Ind J Clin Biochem 32, 200–206 (2017). https://doi.org/10.1007/s12291-016-0584-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-016-0584-7